NVDA
NVIDIA
-- 130.390 TSLA
Tesla
-- 479.860 QUBT
Quantum Computing
-- 16.790 AVGO
Broadcom
-- 240.230 PLTR
Palantir
-- 74.390 
Possible upcoming catalyst? Make a note! Well ifn you want? Hehehe
$AN2 Therapeutics (ANTX.US)$ Plan to report Phase 2 topline results in August 2024 from ongoing Phase 2/3 trial (EBO-301) in treatment-refractory Mycobacterium avium Complex (TR-MAC)
Phase 3 continues for 97 patients enrolled before the voluntary enrollment pause; lifting of the Phase 3 enrollment pause to be determined after review of unblinded Phase 2 data and discussions with the FDA
Phase 3 continues for 97 patients enrolled before the voluntary enrollment pause; lifting of the Phase 3 enrollment pause to be determined after review of unblinded Phase 2 data and discussions with the FDA
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
NVDAvsTSLA : No one knows the results only the company themselves
Trytosaveabit OP NVDAvsTSLA : That’s why I said ( upcoming ) meaning later when they release the results/data! If it’s good it could be a catalyst. Hehehe
NVDAvsTSLA Trytosaveabit OP : Agree. Back to $20 is easy once the tests are good
Trytosaveabit OP NVDAvsTSLA : That would be a great thing to see! GL to ya![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
Javy : Do you think it will be good? The institution are expecting it to be good
Trytosaveabit OP Javy : I do expect it to be good! JMO GL